130 related articles for article (PubMed ID: 3212605)
1. Effects of naftidrofuryl on pathological EEG topography.
Foit A; Bischoff W; Breinlinger U; Kornhuber HH
Vasa Suppl; 1988; 24():56-9. PubMed ID: 3212605
[No Abstract] [Full Text] [Related]
2. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
Grossmann W; Standl A; May U
Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
[No Abstract] [Full Text] [Related]
3. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
4. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
[No Abstract] [Full Text] [Related]
5. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
Kriessmann A; Neiss A
Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
[No Abstract] [Full Text] [Related]
6. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
7. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
Brodie NH
Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
[No Abstract] [Full Text] [Related]
8. Naftidrofuryl for intermittent claudication: a double-blind controlled trial.
Ruckley CV; Callam MJ; Ferrington CM; Prescott RJ
Br Med J; 1978 Mar; 1(6113):622. PubMed ID: 343869
[No Abstract] [Full Text] [Related]
9. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
Ciammaichella A; Solitro A; Arcuri P
Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
[No Abstract] [Full Text] [Related]
10. [Effects of naftidrofuryl through prolonged intra-arterial perfusion in obliterating arteriopathies of the lower limbs].
Cospite M; Ferrara F; Ballo M; Lo Presti T; Raimondi F; Meli F; Milio G
Minerva Cardioangiol; 1980 May; 28(5):359-66. PubMed ID: 7207826
[No Abstract] [Full Text] [Related]
11. A single blind study of naftidrofuryl in the treatment of peripheral vascular disorders in general practice.
Clyne MB; Lask A
Br J Clin Pract; 1978 Jun; 32(6):169-71. PubMed ID: 354670
[No Abstract] [Full Text] [Related]
12. Evaluation of a vasoactive substance, naftidrofuryl, during the rehabilitation phase after an ischaemic insult.
Ducarne H
Curr Med Res Opin; 1986; 10(1):58-71. PubMed ID: 3698655
[TBL] [Abstract][Full Text] [Related]
13. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
Becker HM; Elert O; Häring R; Maurer PC; Raithel D; Sperling M; Stockmann U; Storz LW; Hirche H
Med Welt; 1979 Oct; 30(43):1602-6. PubMed ID: 514039
[No Abstract] [Full Text] [Related]
15. [Naftidrofuryl in cerebrovascular sclerosis. Ophthalmodynamic findings in acute and long term experiment].
Finke J; Kettlitz UP
ZFA (Stuttgart); 1976 Sep; 52(27):1400-3. PubMed ID: 790807
[No Abstract] [Full Text] [Related]
16. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
[TBL] [Abstract][Full Text] [Related]
17. Hemorrheological, micro- and macrocirculatory effects of naftidrofuryl in an acute study: a randomized, placebo-controlled, double-blind individual comparison.
Jung F; Kiesewetter H; Mrowietz C; Leipnitz G; Braun B; Wappler M; Scheffler P; Wenzel E
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):507-14. PubMed ID: 3679623
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
19. [The effect of naftidrofuryl on platelet aggregation].
Sensale P
Acta Neurol Quad (Napoli); 1980; 41():86-92. PubMed ID: 7293743
[No Abstract] [Full Text] [Related]
20. [Naftidrofuryl. (Pralixene)].
Naess K
Tidsskr Nor Laegeforen; 1980 Mar; 100(8-9):518-9. PubMed ID: 7385216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
